Related Experiment Video
Updated: Jul 14, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Biomarkers for inflammatory bowel disease
1Department of Pathology and Laboratory Medicine, The Mayo Clinic, 200 First Street SW, Rochester MN 55905, USA. foley.kevin@mayo.edu
Abstract:
Currently there is no single biomarker or panel of markers which is diagnostic of IBD generally, or CD and UC specifically. Diagnosis of IBD still requires radiographic, endoscopic, and microscopic examination. Since GI markers of inflammation are continuously being uncovered, and given that statistical power can be enhanced with multi-marker panels, we are hopeful that the medical laboratory will have the ability, in the near future, to support a non-invasive diagnosis of an inflammatory bowel disease.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
